We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HUGE market cap is 16.67M. The company's latest EPS is USD -0.6131 and P/E is -0.72.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.11M | 1.26M | -8.15M | -4.38M | -5.5M |
| Net Income | -7.13M | -6.15M | -9.96M | -5.49M | -1.06M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 88k | 257k | 15k | 0 | 0 |
| Operating Income | -25.28M | -29.86M | -28.77M | -20.23M | -13.72M |
| Net Income | -22.71M | -52.01M | -31.8M | -35.29M | -23.61M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.58M | 38.41M | 29.48M | 21.41M | 18.94M |
| Total Liabilities | 7.44M | 7.87M | 8.62M | 5.86M | 4.2M |
| Total Equity | 36.14M | 30.54M | 20.86M | 15.55M | 14.75M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 52.78M | 57.45M | 41.97M | 62.96M | 38.41M |
| Total Liabilities | 1.74M | 9.23M | 5.66M | 8.83M | 7.87M |
| Total Equity | 51.03M | 48.22M | 36.31M | 54.13M | 30.54M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.01M | -28.33M | -4.76M | -8.26M | -9.98M |
| Investing | 12.52M | 12.12M | N/A | N/A | -270k |
| Financing | -2.02M | -2.07M | -3M | -3.05M | -3.1M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.49M | -18.23M | -19.13M | -20.75M | -28.33M |
| Investing | -9.99M | -307k | 6.52M | 269k | 12.12M |
| Financing | 44.88M | 5.33M | 24.17M | 38.21M | -2.07M |
| Market Cap | 16.67M |
| Price to Earnings Ratio | -0.72 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 38.5M |
| Average Volume (1 week) | 334.93k |
| Average Volume (1 Month) | 195.19k |
| 52 Week Change | -69.93% |
| 52 Week High | 1.6799 |
| 52 Week Low | 0.4184 |
| Spread (Intraday) | 0.01 (2.27%) |
| Company Name | FSD Pharma Inc |
| Address |
199 bay street, suite 4000 toronto, ontario M5L 1A9 |
| Website | https://www.fsdpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
